Nucleoside-Analog-1

CAS No. 876707-99-2

Nucleoside-Analog-1( —— )

Catalog No. M16365 CAS No. 876707-99-2

A 4′-azidocytidine analogue that shows anti-HCV activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 Get Quote
50MG 1341 Get Quote
100MG 1791 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Nucleoside-Analog-1
  • Note
    Research use only, not for human use.
  • Brief Description
    A 4′-azidocytidine analogue that shows anti-HCV activity.
  • Description
    A 4′-azidocytidine analogue that shows anti-HCV activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    876707-99-2
  • Formula Weight
    267.1983
  • Molecular Formula
    C9H9N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C1=CN2C3C(C(C(O3)(CO)N=[N+]=[N-])O)OC2=NC1=O
  • Chemical Name
    6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-azido-2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, (2R,3S,3aS,9aR)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Smith DB, et al. J Med Chem. 2009 May 14;52(9):2971-8. 2. Smith DB, et al. J Med Chem. 2009 May 14;52(9):2971-8.
molnova catalog
related products
  • HCV-IN-4

    HCV-IN-4 is a potent and orally active HCV NS5A inhibitor, shows great potency against GT1a, GT2b, GT3a, GT1a Y93H and GT1a L31V, with EC90s of 3 pM, 0.3 nM, 0.01 nM, 0.5 nM and 0.02 nM, respectively.

  • Ombitasvir

    Ombitasvir is an orally bioavailable and potent inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A).with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5 and 366 pM against genotype 6a.

  • IDX-17119

    IDX-17119 is a potent, non-nucleoside, HCV NS5B RdRp inhibitor with IC50 of 0.4 nM in replicon luciferase assay.